{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:44:55Z","timestamp":1775882695369,"version":"3.50.1"},"reference-count":44,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6632-25","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:10:32Z","timestamp":1775513432000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's Thyroiditis"],"prefix":"10.2169","author":[{"given":"Yuichiro","family":"Iwamoto","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Komi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Kawasaki Medical School Hospital Center for Doctors' Career Development, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuna","family":"Fukuma","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Husebye ES, Anderson MS, K\u00e4mpe O. Autoimmune Polyendocrine Syndromes. New England Journal of Medicine 378: 1132-1141, 2018.","DOI":"10.1056\/NEJMra1713301"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bj\u00f8rklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L. Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach. Autoimmun Rev 21: 103135, 2022.","DOI":"10.1016\/j.autrev.2022.103135"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kounatidis D, Kontos G, Kotsi E, Kaparou P, Avgoustou E, Vallianou N, et al. Autoimmune polyglandular syndrome with shock and high anion gap metabolic acidosis. Am J Med Sci 368: 162-166, 2024.","DOI":"10.1016\/j.amjms.2024.05.019"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F. Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest 46: 643-665, 2023.","DOI":"10.1007\/s40618-022-01994-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fern\u00e1ndez Mir\u00f3 M, Colom Com\u00ed C, Godoy Lorenzo R. Autoinmune polyendocrinopathy. Med Clin (Barc) 157: 241-246, 2021.","DOI":"10.1016\/j.medcle.2021.08.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takahashi K, Anno T, Matsuda A, Kimura Y, Kawasaki F, Kaku K, et al. Case Report: Onset of Type 1 Diabetes Mellitus in a Patient With Ulcerative Colitis and Sjogren's Syndrome Under Euthyroid Hashimoto's Thyroiditis. Front Endocrinol (Lausanne) 13: 836102, 2022.","DOI":"10.3389\/fendo.2022.836102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Horie I, Kawasaki E, Ando T, Kuwahara H, Abiru N, Usa T, et al. Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population. J Clin Endocrinol Metab 97: E1043-E1050, 2012.","DOI":"10.1210\/jc.2011-3109"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, et al. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev 19: 102649, 2020.","DOI":"10.1016\/j.autrev.2020.102649"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campenn\u00ec A, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood\/adolescence. Eur J Endocrinol 176: 133-141, 2017.","DOI":"10.1530\/EJE-16-0737"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev 14: 174-180, 2015.","DOI":"10.1016\/j.autrev.2014.10.016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stramazzo I, Mangino G, Capriello S, Romeo G, Ferrari SM, Fallahi P, et al. CD20 + T lymphocytes in isolated Hashimoto's thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study. J Endocrinol Invest 47: 2865-2871, 2024.","DOI":"10.1007\/s40618-024-02370-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Raji\u0107 M, Djurica S, Milosevi\u0107 DP, Markovi\u0107 N. [Autoimmune haemopoietic disturbances simultaneous with autoimmune thyroid diseases]. Srp Arh Celok Lek 133 (Suppl 1): 52-54, 2005.","DOI":"10.2298\/SARH05S1052R"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kotera T, Itani K, Uchiyama H, Takemoto T, Ooyama K, Hirata K, et al. A Rare Combination of Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Autoimmune Gastritis, Thyroiditis, Hemolysis, and Systemic Lupus Erythematosus. Intern Med 59: 61-65, 2020.","DOI":"10.2169\/internalmedicine.3191-19"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saitoh T, Matsushima T, Saito Y, Yamane A, Yokohoma A, Irisawa H, et al. Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia. Clin Lymphoma Myeloma 8: 62-64, 2008.","DOI":"10.3816\/CLM.2008.n.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kang MY, Hahm JR, Jung TS, Lee GW, Kim DR, Park MH. A 20-year-old woman with Hashimoto's thyroiditis and Evans' syndrome. Yonsei Med J 47: 432-436, 2006.","DOI":"10.3349\/ymj.2006.47.3.432"},{"key":"16","unstructured":"16. Hashizume M, Okiyama R, Orimo S, Arai M, Hiyamura E. [Oculopharyngeal myopathy with autoimmune disease]. Rinsho Shinkeigaku 33: 334-337, 1993."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Oh HJ, Yun MJ, Lee ST, Lee SJ, Oh SY, Sohn I. Evans syndrome following long-standing Hashimoto's thyroiditis and successful treatment with rituximab. Korean J Hematol 46: 279-282, 2011.","DOI":"10.5045\/kjh.2011.46.4.279"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. De La, Puerta R, Carpio N, Sanz G, Solves P. A case of megaloblastic anemia simulating a cold autoimmune hemolytic anemia. Immunohematology 36: 89-92, 2020.","DOI":"10.21307\/immunohematology-2020-046"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kandinata SG, Soelistijo SA, Amrita PNA. Graves' Disease Presenting as Autoimmune Hemolytic Anemia. Am J Case Rep 22: e930705, 2021.","DOI":"10.12659\/AJCR.930705"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ogihara T, Katoh H, Yoshitake H, Iyori S, Saito I. Hyperthyroidism associated with autoimmune hemolytic anemia and periodic paralysis: a report of a case in which antihyperthyroid therapy alone was effective against hemolysis. Jpn J Med 26: 401-403, 1987.","DOI":"10.2169\/internalmedicine1962.26.401"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. O'Brien D, Lyons DJ, Fielding JF. A case of Graves' disease associated with autoimmune haemolytic anaemia. Ir J Med Sci 158: 155, 1989.","DOI":"10.1007\/BF02943059"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Mukai M, Sagawa A, Watanabe I, Tanimura K, Shimizu M, Oki I, et al. [A case of autoimmune hemolytic anemia associated with Graves' disease]. Nihon Naika Gakkai Zasshi 75: 644-649, 1986.","DOI":"10.2169\/naika.75.644"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Butt N, Khan MA, Abid Z, Haleem F. A Case of Polyautoimmunity: Celiac Hepatitis, Grave's Disease and Autoimmune Hemolytic Anemia. J Coll Physicians Surg Pak 29: S106-S108, 2019.","DOI":"10.29271\/jcpsp.2019.12.S106"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Sugisaki M, Ishizaki T, Iriuchishima H, Shimizu H, Yanagisawa K, Ogawa Y, et al. [Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth]. Rinsho Ketsueki 60: 924-928, 2019.","DOI":"10.11406\/rinketsu.60.924"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Moore JA, Gliga L, Nagalla S. Thyroid storm and warm autoimmune hemolytic anemia. Transfus Apher Sci 56: 606-608, 2017.","DOI":"10.1016\/j.transci.2017.08.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Naji P, Kumar G, Dewani S, Diedrich WA, Gupta A. Graves' disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature. Case Rep Med 2013: 194542, 2013.","DOI":"10.1155\/2013\/194542"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ikeda K, Maruyama Y, Yokoyama M, Kato N, Yamanoto H, Kaguchi Y, et al. Association of Graves' disease with Evans' syndrome in a patient with IgA nephropathy. Intern Med 40: 1004-1010, 2001.","DOI":"10.2169\/internalmedicine.40.1004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ushiki T, Masuko M, Nikkuni K, Terukina-Yoshida J, Momotsu-Nanba A, Morikawa H, et al. Successful remission of Evans syndrome associated with Graves' disease by using propylthiouracil monotherapy. Intern Med 50: 621-625, 2011.","DOI":"10.2169\/internalmedicine.50.4319"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Shimohakamada Y, Fukuda N, Shinohara K, Inoue Y. [Simultaneous occurrence of Basedow's disease and autoimmune hemolytic anemia]. Rinsho Ketsueki 42: 328-331, 2001.","DOI":"10.11406\/rinketsu.42.328"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Jovanovic MD, Zivaljevic VR, Diklic AD, Rovcanin BR, G VZ, Paunovic IR. Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases. Eur Arch Otorhinolaryngol 274: 997-1004, 2017.","DOI":"10.1007\/s00405-016-4303-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Regal M, P\u00e1ramo C, Luna Cano R, P\u00e9rez M\u00e9ndez LF, Sierra JM, Rodr\u00edguez I, et al. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest 22: 191-197, 1999.","DOI":"10.1007\/BF03343540"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Michel M. Adult Evans' Syndrome. Hematol Oncol Clin North Am 36: 381-392, 2022.","DOI":"10.1016\/j.hoc.2021.12.004"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Matsumoto M. [Basedow disease associated with Evans syndrome]. Rinsho Ketsueki 46: 1118-1122, 2005.","DOI":"10.11406\/rinketsu.46.1118"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lio S, Albin M, Girelli G, Perrone MP, Gandolfo G, Conti L, et al. Abnormal thyroid function test results in patients with Fisher-Evans syndrome. J Endocrinol Invest 16: 163-167, 1993.","DOI":"10.1007\/BF03344937"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hegde UM. Platelet antibodies in immune thrombocytopenia. Blood Rev 6: 34-42, 1992.","DOI":"10.1016\/0268-960X(92)90006-C"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Cordiano I, Salvan F, Randi ML, Ruffatti MA, Steffan A, Girolami A, et al. Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. J Clin Immunol 16: 340-347, 1996.","DOI":"10.1007\/BF01541670"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Utiyama SRR, De Bem RS, Skare TL, De Carvalho GA, Teixeira LM, Bertolazo M, et al. Anti-parietal cell antibodies in patients with autoimmune thyroid diseases. J Endocrinol Invest 41: 523-529, 2018.","DOI":"10.1007\/s40618-017-0755-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Checchi S, Montanaro A, Ciuoli C, Brusco L, Pasqui L, Fioravanti C, et al. Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid 20: 1385-1389, 2010.","DOI":"10.1089\/thy.2010.0041"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, et al. Atrophic Body Gastritis in Patients With Autoimmune Thyroid Disease: An Underdiagnosed Association. Archives of Internal Medicine 159: 1726-1730, 1999.","DOI":"10.1001\/archinte.159.15.1726"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ihara T, Ihara N, Kushima R, Haruma K. Rapid Progression of Autoimmune Gastritis after Helicobacter pylori Eradication Therapy. Intern Med 62: 1603-1609, 2023.","DOI":"10.2169\/internalmedicine.0533-22"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Castellana C, Eusebi LH, Dajti E, Iascone V, Vestito A, Fusaroli P, et al. Autoimmune Atrophic Gastritis: A Clinical Review. Cancers 16: 1310, 2024.","DOI":"10.3390\/cancers16071310"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Flesch BK, Matheis N, Alt T, Weinstock C, Bux J, Kahaly GJ. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 99: E177-E182, 2014.","DOI":"10.1210\/jc.2013-2852"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wallaschofski H, Meyer A, Tuschy U, Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 35: 120-124, 2003.","DOI":"10.1055\/s-2003-39059"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocrinol Metab 81: 2559-2563, 1996.","DOI":"10.1210\/jc.81.7.2559"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6632-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:51:40Z","timestamp":1775879500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6632-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":44,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6632-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6632-25"}}